Anthropic’s $1.5B AI Venture with Wall Street Firms Targets Private Equity Market 
Spirit Airlines Shuts Down Flights, Issues Refunds After Financial Collapse 
Supreme Court Asked to Reinstate Mail-Order Access to Abortion Pill Mifepristone 
U.S. Cybersecurity Pushes Faster Patch Deadlines Amid Rising AI-Driven Threats 
Strategy Reports Q1 Loss as Bitcoin Holdings Trigger $14.46 Billion Unrealized Hit 
Coles Group Q3 Sales Rise Driven by Supermarkets and E-Commerce Growth 
Samsung Appoints New TV Business Head Amid Rising Competition from Chinese Rivals 
Regis Resources and Vault Minerals to Merge in $10.7B Gold Deal 
Strategy Hints at Bitcoin Sales to Cover Dividends After Massive Q1 Loss 
Pinterest Stock Surges After Strong Q1 2026 Earnings Beat Expectations 
NAB First-Half Earnings Miss Forecasts Amid Rising Global Risks 
Palantir Reports Record Growth, Raises 2026 Revenue Outlook Above Expectations 
Middle East Conflict Impacts Australia and New Zealand Businesses 
GameStop Proposes $56 Billion eBay Acquisition in Bold Strategic Move 
Supermicro Forecasts Strong Q4 Revenue Growth as AI Server Demand Surges 
 - EconoTimes)
Dublin, May 08, 2018 -- The "Point-of-Care Diagnostics & Biosensors Europe 2018" conference has been added to ResearchAndMarkets.com's offering.
Point-of-Care Diagnostics Europe 2018 brings together the key opinion leaders from both academia and industry, this annual conference will discuss the expanding Point-of-Care Diagnostics and Global Health fields and provide the most up-to-date presentations from leaders in these fields and offer networking and engagement opportunities with delegates from around the world.
This conference will provide an overview of the point-of-care (POC) testing landscape, from novel technologies to regulatory approval. Experts in these fields will share their views on point-of-care in the clinical setting. The aim of this meeting is to bring together life science researchers that work at the interface between biology and chemistry and technology development to discuss problems, highlight solutions and facilitating collaborations. Also, we frame the role of POC testing in the expanding Global Health field and highlight opportunities existing in many parts of the world.
This conference covers POC Detection, POC Diagnostics and POC-based Treatment Options as part of the Comprehensive Coverage of this Expanding Field. The POC testing field is expanding focused not only on infectious disease diagnostics (which represents 80% of the marketplace) but also with cancer and cardiovascular disease focus. We address each of these segments in this conference.
Agenda:
- Impact of Microfluidics/Lab-on-a-Chip Technologies for Point-of-Care (POC) Diagnostics Applications
- Low Cost POC Diagnostics Platforms for Deployment Worldwide
- POC Diagnostics for Global Health: A Worldwide Perspective
- POC Diagnostics in Cardiovascular Disease Testing
- Point-of-Care Diagnostics in Infectious Disease Testing
- Wearable and Implantable Devices
- Worldwide Regulatory Trends and Hurdles in the Deployment of POC Testing
For more information about this conference visit https://www.researchandmarkets.com/research/nqcksd/european?w=12
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Biotechnology, Point-of-Care Diagnostics
